Amyloid Solution Inc.

Amyloid Solution Inc.

Private
South KoreaHealthcare & Life Scienceshttps://amyloidsolution.com

Last Round

Series C

May 3, 2022

Est. Valuation

$185.35M

Total Funding Raised

$64.65M

Company Overview

Amyloid Solution Inc. is a biotechnology company that develops therapeutic drugs for the treatment of Alzheimer's disease. The company's research focuses on disaggregating beta-amyloid oligomers and fibrils, as well as targeting glial cell dysfunction.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

Alzheimer's therapeuticssmall molecule drugsdrug discoverydisease-modifying therapiespreclinical biotechpharma licensingamyloid beta inhibitortau protein inhibitorbiopharma partnershipsneurodegenerative diseasedrug developmentglia-targeted therapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Amyloid Solution Inc. Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Amyloid Solution Inc. Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series CMay 3, 2022
Series B ExtensionJun 20, 2020
Series BApr 6, 2020
Series AMar 26, 2019

Amyloid Solution Inc. Investors

Notable investors and investment history

InvestorRounds
KB InvestmentSeries B Extension
POSCO CapitalSeries B Extension, Series C
Starset InvestmentSeries A
TS InvestmentSeries A, Series B, Series C
Innopolis PartnersSeries A
Wonik Investment PartnersSeries A
KTB VenturesSeries A

Amyloid Solution Inc. Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Amyloid Solution Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Amyloid Solution Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSouth Korea
Employee Range20
Year Founded2017
Last FundingMay 3, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.